Cargando…

Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2

AIMS: Residual beta cell function in type 1 diabetes (T1D) is associated with lower risk of complications. Autoantigen therapy with GAD-alum (Diamyd) given in 3 intralymphatic injections with oral vitamin D has shown promising results in persons with T1D carrying the human leukocyte antigen (HLA) DR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowak, Christoph, Lind, Marcus, Sumnik, Zdenek, Pelikanova, Terezie, Nattero-Chavez, Lía, Lundberg, Elena, Rica, Itxaso, Martínez-Brocca, Maria A, Ruiz de Adana, MariSol, Wahlberg, Jeanette, Hanas, Ragnar, Hernandez, Cristina, Clemente-León, Maria, Gómez-Gila, Ana, Ferrer Lozano, Marta, Sas, Theo, Pruhova, Stepanka, Dietrich, Fabricia, Puente-Marin, Sara, Hannelius, Ulf, Casas, Rosaura, Ludvigsson, Johnny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721339/ https://www.ncbi.nlm.nih.gov/pubmed/35665810 http://dx.doi.org/10.1210/clinem/dgac343

Ejemplares similares

Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
por: Ludvigsson, Johnny, et al.
Publicado: (2021)

Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes
por: Hannelius, Ulf, et al.
Publicado: (2020)

Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype
por: Puente-Marin, Sara, et al.
Publicado: (2023)

Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes
por: Barcenilla, Hugo, et al.
Publicado: (2022)

Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes
por: Tavira, Beatriz, et al.
Publicado: (2018)

Association between treatment effect on C‐peptide preservation and HbA1c in meta‐analysis of glutamic acid decarboxylase (GAD)‐alum immunotherapy in recent‐onset type 1 diabetes
por: Nowak, Christoph, et al.
Publicado: (2022)

Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD(65)-induced immune response
por: Tavira, Beatriz, et al.
Publicado: (2017)

Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)
por: Casas, Rosaura, et al.
Publicado: (2022)

Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocol
por: Ludvigsson, Johnny, et al.
Publicado: (2022)

Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial
por: Axelsson, Stina, et al.
Publicado: (2013)

Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
por: Axelsson, Stina, et al.
Publicado: (2011)

Intralymphatic immunotherapy
por: Senti, Gabriela, et al.
Publicado: (2015)

Intralymphatic Histiocytosis
por: Garcia-Mouronte, Emilio, et al.
Publicado: (2022)

Two Cases of Diabetic Ketoacidosis in HNF1A-MODY Linked to Severe Dehydration: Is it time to change the diagnostic criteria for MODY?
por: Pruhova, Stepanka, et al.
Publicado: (2013)

Response to Letter to the Editor from Youn Hee Jee: “Familial Short Stature - A Novel Phenotype of Growth Plate Collagenopathies”
por: Plachy, Lukas, et al.
Publicado: (2021)

Intralymphatic Histiocytosis: An Unusual Presentation
por: Blackwell, Timothy J., et al.
Publicado: (2021)

Combined vitamin D, ibuprofen and glutamic acid decarboxylase-alum treatment in recent onset Type I diabetes: lessons from the DIABGAD randomized pilot trial
por: Ludvigsson, Johnny, et al.
Publicado: (2020)

The Transplantability of Tumours by Intravenous and Intralymphatic Routes
por: Wallace, A. C., et al.
Publicado: (1965)

Papillary intralymphatic angioendothelioma: Dabska tumor()()
por: Silva, Thadeu Santos, et al.
Publicado: (2020)

Neutrophil Extracellular Trap Induced Dendritic Cell Activation Leads to Th1 Polarization in Type 1 Diabetes
por: Parackova, Zuzana, et al.
Publicado: (2020)

Elevated Biomarkers of NETosis in the Serum of Pediatric Patients With Type 1 Diabetes and Their First-Degree Relatives
por: Klocperk, Adam, et al.
Publicado: (2021)

Search for a time- and cost-saving genetic testing strategy for maturity-onset diabetes of the young
por: Dusatkova, Petra, et al.
Publicado: (2022)

The disposition of cytotoxic agents after intralymphatic infusion.
por: Calnan, J. S., et al.
Publicado: (1967)

Papillary intralymphatic angioendothelioma: An extremely rare tumor
por: Kaplan, Güven Ozan, et al.
Publicado: (2021)

Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D
por: Björklund, Anneli, et al.
Publicado: (2022)

Data on microbial DNA-induced IL-1β production in monocytes of type 1 diabetes patients
por: Zentsova, Irena, et al.
Publicado: (2019)

Allergen-specific intralymphatic immunotherapy in human and animal studies
por: Kim, Seon Tae, et al.
Publicado: (2017)

Intralymphatic Histiocytosis Associated with Osteoarthritis: A Case Report
por: Koo, Taehan, et al.
Publicado: (2022)

Alum Pastilles
Publicado: (1860)

Alum as an Emetic
Publicado: (1854)

Is Alum Poisonous?
Publicado: (1879)

Alum in Pertusis
Publicado: (1847)

Alum as an Emetic
Publicado: (1854)

Bougies with Alum
Publicado: (1845)

Familial Short Stature - a Novel Phenotype of Growth Plate Collagenopathies
por: Plachy, Lukas, et al.
Publicado: (2021)

Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children
por: Zhao, Lue Ping, et al.
Publicado: (2020)

Stratifying the Genetic Aetiology in Children Born Small for Gestational Age With Persistent Short Stature (SGA-SS)
por: Toni, Ledjona, et al.
Publicado: (2021)

DQ2, DQ7 and DQ8 Distribution and Clinical Manifestations in Celiac Cases and Their First-Degree Relatives
por: Araya, Magdalena, et al.
Publicado: (2015)

Low-Carbohydrate Diet among Children with Type 1 Diabetes: A Multi-Center Study
por: Neuman, Vit, et al.
Publicado: (2021)

How alum works
por: Bashyam, Hema
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ipi5b30bbl8jd73sie8djousei